Annual Revenue ($)

Intra-Cellular Therapies revenue was $22.81 m in FY, 2020

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2019FY, 2020
Revenue$2.74 m$577.3 k$91.36 k$330.7 k$245.84 k$60.61 k$22.81 m
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2020Q2, 2020
Revenue$667.96 k$167.79 k$219.24 k$124.41 k$3.32 k$57.39 k$228.45 k$4.36 k$95.29 k$114.74 k$30.75 k$1.08 m$1.91 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Intra-Cellular Therapies revenue breakdown by business segment: 33.6% from License and collaboration revenue and 66.4% from Grant Revenue

FY, 2015FY, 2014
License and collaboration revenue$30.66 k$547.55 k
Grant Revenue$60.71 k$29.76 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu